tirzepatide launch for Weight Loss Lilly Launches Mounjaro (tirzepatide), offering

We use industry standard TLS 1.2 encryption for all sensitive data in transit to be compliant with HIPAA regulations and SOC 2 certification standards, ensuring that your health information is handled with the utmost care and confidentiality

Retatrutide remains in Phase 3 clinical trials with FDA approval expected between Q3 2026 and Q1 2027

doi:10.3390/ijms20040867 [PubMed] [MDPI] [PubMed] Viroonudompho D, Kanjanachumpol S, Sirisate S

A treatment-related increase in malignant thyroid C-cell carcinomas was observed in all male liraglutide-treated groups with incidences of 2%, 8%, 6%, and 14% and in females at 0.25 and 0.75 mg/kg/day with incidences of 0%, 0%, 4%, and 6% in 0 (control), 0.075, 0.25, and 0.75 mg/kg/day groups, respectively

Your own cells become the source